Profile data is unavailable for this security.
About the company
PT Tempo Scan Pacific Tbk is an Indonesia-based company engaged in the pharmaceuticals, consumer products, and cosmetics industry. The Company's segments include Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment conducts marketing of consumer health products, including over-the-counter drugs, vitamins, minerals and supplements (VMS), beverages, nutritional products, herbal products, and prescription medicines. The Consumer Products and Cosmetics segment markets and distributes its own branded products as well as licensed cosmetics products. The Distribution Services segment distributes products to customers and serves customers from various sales branches throughout Indonesia, covering pharma, modern trade, and general trade channels. It also markets and distributes its products overseas through its international business units. Its business network covers approximately 238 locations consisting of over 48 branches.
- Revenue in IDR (TTM)13.50tn
- Net income in IDR1.31tn
- Incorporated1971
- Employees4.50k
- LocationTempo Scan Pacific Tbk PTLantai 16, Tempo Scan TowerJl. HR. Rasuna Said Kav. 3-4JAKARTA 12950IndonesiaIDN
- Phone+62 2 129218888
- Fax+62 2 129209999
- Websitehttps://www.temposcangroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Jibeier Pharmaceutical Co Ltd | 1.95tn | 523.24bn | 10.96tn | 1.45k | 20.01 | 2.22 | -- | 5.64 | 1.25 | 1.25 | 4.64 | 11.31 | 0.3848 | 2.99 | 3.78 | 613,955.40 | 10.34 | 9.77 | 11.16 | 10.66 | 87.99 | 88.44 | 26.86 | 23.29 | 9.03 | -- | 0.0014 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
| Shanghai OPM Biosciences Co Ltd | 630.06bn | 83.54bn | 11.16tn | 285.00 | 133.41 | 2.42 | -- | 17.72 | 0.3324 | 0.3324 | 2.52 | 18.31 | 0.1259 | 2.23 | 3.59 | 1,008,039.00 | 1.63 | 4.34 | 1.69 | 4.65 | 57.28 | 58.31 | 12.93 | 23.40 | 17.02 | -- | 0.0311 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
| Aarti Pharmalabs Ltd | 3.69tn | 428.14bn | 11.18tn | 1.63k | 26.12 | 3.21 | 19.40 | 3.03 | 25.16 | 25.16 | 217.12 | 204.88 | 0.7733 | 1.62 | 4.59 | 12,095,750.00 | 8.96 | -- | 11.86 | -- | 45.56 | -- | 11.59 | -- | 0.9611 | 17.12 | 0.1723 | -- | -4.76 | -- | 12.10 | -- | -- | -- |
| Hunan Fangsheng Pharmaceutical Co Ltd | 3.86tn | 598.64bn | 11.21tn | 1.69k | 18.64 | 3.20 | -- | 2.90 | 0.6244 | 0.6244 | 4.05 | 3.63 | 0.5513 | 1.43 | 6.70 | 1,044,835.00 | 8.34 | 5.39 | 14.83 | 9.37 | 69.28 | 66.91 | 15.12 | 8.95 | 0.4736 | -- | 0.3161 | 46.47 | -9.12 | 9.15 | -34.64 | 20.68 | 23.91 | 4.75 |
| Eyepoint Pharmaceuticals Inc | 724.78bn | -1.64tn | 11.33tn | 121.00 | -- | 2.57 | -- | 15.63 | -2.01 | -2.01 | 0.9018 | 4.09 | 0.1983 | 1.05 | 106.19 | 377,793.40 | -44.94 | -40.44 | -59.48 | -47.79 | 91.48 | 83.45 | -226.57 | -186.23 | 5.45 | -- | 0.00 | -- | 11.14 | -- | 30.77 | -- | -- | -- |
| Shouyao Holdings Co Ltd | 8.84bn | -459.45bn | 11.35tn | 185.00 | -- | 6.01 | -- | 1,284.87 | -1.41 | -1.41 | 0.0271 | 5.79 | 0.0038 | 0.1616 | 5.03 | 21,779.19 | -19.57 | -37.24 | -21.64 | -42.63 | 95.48 | 96.03 | -5,199.60 | -2,251.77 | 7.06 | -- | 0.0087 | -- | 186.18 | -23.51 | -6.76 | -- | 34.59 | -- |
| Tempo Scan Pacific Tbk PT | 13.50tn | 1.31tn | 11.73tn | 4.50k | 8.96 | 1.39 | 6.58 | 0.8683 | 290.18 | 290.18 | 2,994.05 | 1,873.20 | 1.15 | 4.00 | 8.97 | 2,974,379,000.00 | 12.42 | 9.56 | 17.12 | 13.12 | 38.32 | 35.91 | 10.79 | 7.85 | 2.23 | -- | 0.0987 | 44.59 | 7.06 | 5.40 | 17.55 | 18.12 | -6.87 | 25.59 |
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 11.40m | 0.25% |
| FIL Investment Management (Singapore) Ltd.as of 30 Sep 2024 | 9.19m | 0.20% |
| Samarang LLPas of 30 Jun 2022 | 8.00m | 0.18% |
| Niche Asset Management Ltd.as of 30 Jun 2024 | 1.77m | 0.04% |
| Segall Bryant & Hamill LLCas of 30 Sep 2024 | 1.25m | 0.03% |
| FIL Investments Internationalas of 30 Jun 2024 | 816.40k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 756.04k | 0.02% |
| PT Manulife Aset Manajemen Indonesiaas of 31 Dec 2023 | 647.60k | 0.01% |
| Acadian Asset Management LLCas of 30 Jun 2024 | 565.78k | 0.01% |
| Pheim Asset Management Sdn. Bhd.as of 21 Nov 2022 | 465.30k | 0.01% |
